SOXC Transcription Factors as Diagnostic Biomarkers and Therapeutic Targets for Arthritis

Osteoarthritis (OA) and rheumatoid arthritis (RA) are two common disorders that disrupt the quality of life of millions of people. These two chronic diseases cause damage to the joint cartilage and surrounding tissues of more than 220 million people worldwide. Sex-determining region Y-related (SRY)...

Full description

Bibliographic Details
Main Authors: Emad A. Ahmed, Abdullah M. Alzahrani
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/4/4215
_version_ 1797620326064979968
author Emad A. Ahmed
Abdullah M. Alzahrani
author_facet Emad A. Ahmed
Abdullah M. Alzahrani
author_sort Emad A. Ahmed
collection DOAJ
description Osteoarthritis (OA) and rheumatoid arthritis (RA) are two common disorders that disrupt the quality of life of millions of people. These two chronic diseases cause damage to the joint cartilage and surrounding tissues of more than 220 million people worldwide. Sex-determining region Y-related (SRY) high-mobility group (HMG) box C, SOXC, is a superfamily of transcription factors that have been recently shown to be involved in various physiological and pathological processes. These include embryonic development, cell differentiation, fate determination, and autoimmune diseases, as well as carcinogenesis and tumor progression. The SOXC superfamily includes SOX4, SOX11, and SOX12, all have a similar DNA-binding domain, i.e., HMG. Herein, we summarize the current knowledge about the role of SOXC transcription factors during arthritis progression and their potential utilization as diagnostic biomarkers and therapeutic targets. The involved mechanistic processes and signaling molecules are discussed. SOX12 appears to have no role in arthritis, however SOX11 is dysregulated and promotes arthritic progression according to some studies but supports joint maintenance and protects cartilage and bone cells according to others. On the other hand, SOX4 upregulation during OA and RA was documented in almost all studies including preclinical and clinical models. Molecular details have indicated that SOX4 can autoregulate its own expression besides regulating the expression of SOX11, a characteristic associated with the transcription factors that protects their abundance and activity. From analyzing the currently available data, SOX4 seems to be a potential diagnostic biomarker and therapeutic target of arthritis.
first_indexed 2024-03-11T08:39:34Z
format Article
id doaj.art-534553aee3d84ba2b86feac5df53222e
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T08:39:34Z
publishDate 2023-02-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-534553aee3d84ba2b86feac5df53222e2023-11-16T21:11:05ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-02-01244421510.3390/ijms24044215SOXC Transcription Factors as Diagnostic Biomarkers and Therapeutic Targets for ArthritisEmad A. Ahmed0Abdullah M. Alzahrani1Biological Sciences Department, College of Science, King Faisal University, Al Ahsa 31982, Saudi ArabiaBiological Sciences Department, College of Science, King Faisal University, Al Ahsa 31982, Saudi ArabiaOsteoarthritis (OA) and rheumatoid arthritis (RA) are two common disorders that disrupt the quality of life of millions of people. These two chronic diseases cause damage to the joint cartilage and surrounding tissues of more than 220 million people worldwide. Sex-determining region Y-related (SRY) high-mobility group (HMG) box C, SOXC, is a superfamily of transcription factors that have been recently shown to be involved in various physiological and pathological processes. These include embryonic development, cell differentiation, fate determination, and autoimmune diseases, as well as carcinogenesis and tumor progression. The SOXC superfamily includes SOX4, SOX11, and SOX12, all have a similar DNA-binding domain, i.e., HMG. Herein, we summarize the current knowledge about the role of SOXC transcription factors during arthritis progression and their potential utilization as diagnostic biomarkers and therapeutic targets. The involved mechanistic processes and signaling molecules are discussed. SOX12 appears to have no role in arthritis, however SOX11 is dysregulated and promotes arthritic progression according to some studies but supports joint maintenance and protects cartilage and bone cells according to others. On the other hand, SOX4 upregulation during OA and RA was documented in almost all studies including preclinical and clinical models. Molecular details have indicated that SOX4 can autoregulate its own expression besides regulating the expression of SOX11, a characteristic associated with the transcription factors that protects their abundance and activity. From analyzing the currently available data, SOX4 seems to be a potential diagnostic biomarker and therapeutic target of arthritis.https://www.mdpi.com/1422-0067/24/4/4215SOX4SOX11therapeutic targetsrheumatoid arthritisosteoarthritisinflammation
spellingShingle Emad A. Ahmed
Abdullah M. Alzahrani
SOXC Transcription Factors as Diagnostic Biomarkers and Therapeutic Targets for Arthritis
International Journal of Molecular Sciences
SOX4
SOX11
therapeutic targets
rheumatoid arthritis
osteoarthritis
inflammation
title SOXC Transcription Factors as Diagnostic Biomarkers and Therapeutic Targets for Arthritis
title_full SOXC Transcription Factors as Diagnostic Biomarkers and Therapeutic Targets for Arthritis
title_fullStr SOXC Transcription Factors as Diagnostic Biomarkers and Therapeutic Targets for Arthritis
title_full_unstemmed SOXC Transcription Factors as Diagnostic Biomarkers and Therapeutic Targets for Arthritis
title_short SOXC Transcription Factors as Diagnostic Biomarkers and Therapeutic Targets for Arthritis
title_sort soxc transcription factors as diagnostic biomarkers and therapeutic targets for arthritis
topic SOX4
SOX11
therapeutic targets
rheumatoid arthritis
osteoarthritis
inflammation
url https://www.mdpi.com/1422-0067/24/4/4215
work_keys_str_mv AT emadaahmed soxctranscriptionfactorsasdiagnosticbiomarkersandtherapeutictargetsforarthritis
AT abdullahmalzahrani soxctranscriptionfactorsasdiagnosticbiomarkersandtherapeutictargetsforarthritis